112749 20230519145603.0 doi 10.1093/pm/pnaa449 sideral 127841 ART-2021-127841 eng Gonzalez-Martinez, A. Evaluation of the Impact of the COVID-19 Lockdown in the Clinical Course of Migraine 2021 Access copy available to the general public Unrestricted Objective: Previous studies have demonstrated that emotional stress, changes in lifestyle habits and infections can worsen the clinical course of migraine. We hypothesize that changes in habits and medical care during coronavirus disease 2019 (COVID-19) lockdown might have worsened the clinical course of migraine. Design: Retrospective survey study collecting online responses from migraine patients followed-up by neurologists at three tertiary hospitals between June and July 2020. Methods: We used a web-based survey that included demographic data, clinical variables related with any headache (frequency) and migraine (subjective worsening, frequency, and intensity), lockdown, and symptoms of post-traumatic stress. Results: The response rate of the survey was 239/324 (73.8%). The final analysis included 222 subjects. Among them, 201/222 (90.5%) were women, aged 42.5 ± 12.0 (mean±SD). Subjective improvement of migraine during lockdown was reported in 31/222 participants (14.0%), while worsening in 105/222 (47.3%) and was associated with changes in migraine triggers such as stress related to going outdoors and intake of specific foods or drinks. Intensity of attacks increased in 67/222 patients (30.2%), and it was associated with the subjective worsening, female sex, recent insomnia, and use of acute medication during a headache. An increase in monthly days with any headache was observed in 105/222 patients (47.3%) and was related to symptoms of post-traumatic stress, older age and living with five or more people. Conclusions: Approximately half the migraine patients reported worsening of their usual pain during the lockdown. Worse clinical course in migraine patients was related to changes in triggers and the emotional impact of the lockdown. © 2021 The Author(s) 2021. Published by Oxford University Press on behalf of the American Academy of Pain Medicine. info:eu-repo/semantics/openAccess All rights reserved http://www.europeana.eu/rights/rr-f/ 3.637 2021 MEDICINE, GENERAL & INTERNAL 65 / 172 = 0.378 2021 Q2 T2 ANESTHESIOLOGY 16 / 35 = 0.457 2021 Q2 T2 0.733 2021 Medicine (miscellaneous) 2021 Q1 Anesthesiology and Pain Medicine 2021 Q1 4.5 2021 info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion Planchuelo-Gómez, A. Guerrero, A.L. García-Azorín, D. Santos-Lasaosa, S. Universidad de Zaragoza (orcid)0000-0001-5139-6031 Navarro-Pérez, M.P. Universidad de Zaragoza (orcid)0000-0001-6370-218X Odriozola-González, P. Irurtia, M.J. Quintas, S. De Luis-García, R. Gago-Veiga, A.B. 1007 610 Universidad de Zaragoza Dpto. Medicina, Psiqu. y Derm. Area Medicina 22, 9 (2021), 2079-2091 Pain med. Pain Medicine (United States) 1526-2375 643072 http://zaguan.unizar.es/record/112749/files/texto_completo.pdf Versión publicada 2361603 http://zaguan.unizar.es/record/112749/files/texto_completo.jpg?subformat=icon icon Versión publicada oai:zaguan.unizar.es:112749 articulos driver 2023-05-18-16:01:30 ARTICLE